Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,337,940
New position
Shares Held
10,590
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#962
of 2,266 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Park Edge Advisors, LLC holds $9,575,115 across 7 Drug Manufacturers - General names. GILD ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,584 | $4,211,838 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
10,590 | $1,337,940 | |
| 3 | LLY |
ELI LILLY & Co
|
1,061 | $1,272,595 | |
| 4 | ABBV |
AbbVie Inc.
|
3,457 | $869,919 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,381 | $828,633 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,378 | $562,573 | |
| 7 | PFE |
Pfizer Inc
|
20,416 | $491,617 |
All Filings in GILD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,337,940 | 10,590 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||